LanZhou Foci Pharmaceutical Co.,Ltd.

¥7.60As of Sun 8 Nov 2026, 12:00 UTC
SZSE:002644Healthcare
Country China
PE (Fwd) •••
TSR 10Y CAGR (4.36%)
Div yield 1.58%
ROE 3.16%
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 0.28
PE TTM 62.75
TSR TTM (14.77%)
Mkt cap ¥3.881B
ROIC 4.78%
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥9.82
29.21%
(4.80%)
Hold 11|6|10|0|10
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.09
0.09
0.10
0.10
1.52%
6.31%
19.05%
16.03%
Revenue¥M
306.6
308.0
310.7
309.1
10.70%
6.81%
6.25%
6.59%
Peers (US$581.8M)
Cap (US$)
PE
575.6M
26.66x
Capital
TTM
5Y
10Y
Leveragex
1.658
2.017
1.613
EBIT/Intx
2.780
0.277
0.268
Own earn%
23.37
49.53
40.47
Sh yield%
23.00
17.64
19.19
Owners
Insiders/Inst%
2.96
43.59
Short interest%
2.68
SBC / revenue%
5.14
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
6
Op margin range%
25–30
$1 testx
—
Incr. ROIC%
0